Physician
Dermatology
Dr. Narin Apisarnthanarax, MD
|
|
Give Review
Dr. Narin Apisarnthanarax works in the field of Dermatology. He received 3 awards: "Meaningful Use Stage 1 Certification", "Fellow (FASDS)" and "Fellow (FAAD)". Dr. Narin Apisarnthanarax is a published doctor and has 16 publications published. The lastest was: 'Failure to detect human papilloma virus in cutaneous molluscum contagiosum lesions.' He accepts all Medicare patients.
Publications
- Cryofibrinogenemia in a patient with B-Cell lymphoma.
- Cutaneous T-Cell lymphoma. New immunomodulators.
- Response of keratinocytes from normal and psoriatic epidermis to interferon-gamma differs in the expression of zinc-alpha(2)-glycoprotein and cathepsin D.
- Failure to detect human papilloma virus in cutaneous molluscum contagiosum Lesions.
- Therapy options in cutaneous T-Cell lymphoma.
- Extracorporeal photopheresis therapy in the management of steroid-refractory or steroid-dependent cutaneous chronic graft-versus-host disease after allogeneic stem cel...
- Usefulness of flow cytometry in the diagnosis of mycosis fungoides.
- Phase II evaluation of gemcitabine monotherapy for cutaneous T-Cell lymphoma.
- CD25 expression is correlated with histological grade and response to denileukin diftitox in cutaneous T-Cell lymphoma.
- Tazarotene 0.1% gel for refractory mycosis fungoides Lesions: an open-label pilot study.
- Analysis of long-term outcomes of combined modality therapy for cutaneous T-Cell lymphoma.
- Mycosis fungoides with follicular mucinosis displaying aggressive tumor-stage transformation : successful treatment using radiation therapy plus oral bexarotene combin...
- Optimizing bexarotene therapy for cutaneous T-Cell lymphoma.
- Treatment of cutaneous T Cell lymphoma: current status and future directions.
- Treatment of refractory peripheral T-Cell lymphoma with denileukin diftitox (ONTAK).
Schools
University Of Texas Medical Branch At Galveston
Procedures Preformed
- Acne Surgery
- Destruction of Benign Skin Lesion
- Destruction of Malignant Skin Lesion
- Excision of Benign Skin Lesion
- View All
Conditions Treated
- Acne
- Actinic Keratosis
- Atopic Dermatitis (Eczema)
- Basal Cell Carcinoma
- View All
Doctors Specialties
- Dermatology
Accepted Insurances
Awards
- Meaningful Use Stage 1 Certification
- Fellow (FASDS)
- Fellow (FAAD)
Education
-
Case Western Reserve University - University Hospitals -
University of Texas Medical Branch Hospitals -
University of Texas Medical Branch
Drug Facts
| NPI NUMBER | 1669506663 | |
| NPPES Provider LastName | APISARNTHANARAX | |
| NPPES Provider FirstName | NARIN | |
| NPPES Provider ZIPCode | 775984230 | |
| NPPES Provider State | TX | |
| Specialty Description | Dermatology | |
| Total Claim Count | 513.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1669506663 |
| Last Name Of The Provider | APISARNTHANARAX |
| First Name Of The Provider | NARIN |
| View All |
Similar Doctors
|
Dr. Janice R. Chang, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Karan K. Sra, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Saira George, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Prapand Apisarnthanarax, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
Dr. Terry E. Williams, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jia-Yen Chi, MD |
|
|
Dr. Christopher P. Downing, MD |